Source: Teva’s massive agreement to buy Allergan’s generics business continues to ripple its way through the industry. Australia’s Mayne Pharma has scooped up 42 products from the two companies, which are intent on winning antitrust clearance for their $40.5 billion deal. Though smaller in size, Mayne's $652 million buy is…...

Source: Business Wire Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to required withholding…...

Source: By Zeba Siddiqui MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said. The world's fifth-largest maker of generic drugs was the first among its…...

Source: FierceMedicalDevice Healthcare growth investor Essex Woodlands has backed Suneva Medical with a new $25 million financing aimed at expanding its marketing of the only FDA-approved dermal filler that's specifically indicated for smile lines or facial acne scars. In January 2015, Suneva's Bellafill was approved by the agency to treat…...

Source: Reuters Microsoft Corp will buy LinkedIn Corp for $26.2 billion in its biggest-ever deal, a bold stroke by Microsoft CEO Satya Nadella in his efforts to make the venerable software company a major force in next-generation computing. By connecting widely used software like Microsoft Word and PowerPoint with LinkedIn's…...